(Q35219368)

7 August 2017

1 reference

title

Recombinant nematode anticoagulant protein c2 and other inhibitors targeting blood coagulation factor VIIa/tissue factor (English)

1 reference

7 August 2017

1 reference

1 reference

Lee AY

1

1 reference

7 August 2017

Vlasuk GP

series ordinal

2

1 reference

7 August 2017

language of work or name

English

0 references

publication date

1 October 2003

1 reference

Journal of Internal Medicine

7 August 2017

published in

1 reference

7 August 2017

volume

254

1 reference

7 August 2017

issue

4

1 reference

7 August 2017

page(s)

313-321

1 reference

Heparin and low-molecular-weight heparin: mechanisms of action, pharmacokinetics, dosing, monitoring, efficacy, and safety

7 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2003.01224.X

Oral anticoagulants: mechanism of action, clinical effectiveness, and optimal therapeutic range

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2003.01224.X

21 January 2018

New anticoagulant drugs

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2003.01224.X

Anticoagulant repertoire of the hookworm Ancylostoma caninum

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2003.01224.X

Role of zymogen and activated factor X as scaffolds for the inhibition of the blood coagulation factor VIIa-tissue factor complex by recombinant nematode anticoagulant protein c2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2003.01224.X

Nematode anticoagulant protein c2 reveals a site on factor Xa that is important for macromolecular substrate binding to human prothrombinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2003.01224.X

Mechanistic coupling of protease signaling and initiation of coagulation by tissue factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2003.01224.X

A meta-analysis of thromboembolic prophylaxis in total knee arthroplasty

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2003.01224.X

Recombinant nematode anticoagulant protein c2, an inhibitor of the tissue factor/factor VIIa complex, in patients undergoing elective coronary angioplasty

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2003.01224.X

The tissue factor pathway in disseminated intravascular coagulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2003.01224.X

Regulatory role of cytokines in disseminated intravascular coagulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2003.01224.X

Pathogenesis and treatment of disseminated intravascular coagulation in the septic patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2003.01224.X

Efficacy and safety of recombinant human activated protein C for severe sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2003.01224.X

Evolving role of tissue factor and its pathway inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2003.01224.X

Assessment of the safety of recombinant tissue factor pathway inhibitor in patients with severe sepsis: a multicenter, randomized, placebo-controlled, single-blind, dose escalation study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2003.01224.X

Pharmacodynamics of active site-inhibited factor VIIa in endotoxin-induced coagulation in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2003.01224.X

The hemostatic system and angiogenesis in malignancy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2003.01224.X

Active site-blocked activated factor VII as an effective antithrombotic agent: mechanism of action.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2003.01224.X

Regulation of extrinsic pathway factor Xa formation by tissue factor pathway inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2003.01224.X

Prevention of venous thromboembolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2003.01224.X

Reduced ventricular response irregularity is associated with increased mortality in patients with chronic atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2003.01224.X

Antithrombotic effect of tissue factor inhibition by inactivated factor VIIa: an ex vivo human study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2003.01224.X

Ability of recombinant factor VIIa to generate thrombin during inhibition of tissue factor in human subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2003.01224.X

10.1046/J.1365-2796.2003.01224.X

21 January 2018

Identifiers

DOI

1 reference

7 August 2017

1 reference